Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Mannkind Corporation (MNKD)

Pharmaceutical Preparations

https://www.mannkindcorp.com

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

1 CASPER STREET
DANBURY, CT

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/28/2004

Market Cap

1,429,974,000

Shares Outstanding

269,580,000

Weighted SO

269,574,654

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

BMRN --.--%

PCVX --.--%

LQDA --.--%

LEGN --.--%

TECH --.--%

UTHR --.--%

LRMR --.--%

DAWN --.--%

KNSA --.--%

Beta

1.3170

Last Div

0.0000

Range

3.17-6.04

Chg

0.0100

Avg Vol

2508600

Mkt Cap

1429974000

Exch

NASDAQ

Country

US

Phone

818 661 5000

DCF Diff

0.4318

DCF

4.7982

Div Yield

0.0000

P/S

5.7573

EV Multiple

31.1289

P/FV

-6.2888

Div Yield %

0.0000

P/E

120.9653

PEG

3.2083

Payout

0.0000

Current Ratio

4.0736

Quick Ratio

3.7643

Cash Ratio

1.2079

DSO

35.4839

DIO

126.7230

Op Cycle

162.2070

DPO

48.9220

CCC

113.2850

Gross Margin

0.7129

Op Margin

0.1898

Pretax Margin

0.0559

Net Margin

0.0473

Eff Tax Rate

0.5574

ROA

0.0264

ROE

-0.0492

ROCE

0.1296

NI/EBT

0.8453

EBT/EBIT

0.2946

EBIT/Rev

0.1898

Debt Ratio

0.5423

D/E

-1.0660

LT Debt/Cap

126.6427

Total Debt/Cap

16.1571

Int Coverage

2.7016

CF/Debt

0.1688

Equity Multi

-1.9658

Rec Turnover

10.2863

Pay Turnover

7.4609

Inv Turnover

2.8803

FA Turnover

2.7839

Asset Turnover

0.5596

OCF/Share

0.1488

FCF/Share

0.0659

Cash/Share

0.9074

OCF/Sales

0.1636

FCF/OCF

0.4427

CF Coverage

0.1688

ST Coverage

3.1012

CapEx Coverage

1.7942

Div&CapEx Cov

1.7942

P/BV

-6.2888

P/B

-6.2888

P/S

5.7573

P/E

120.9653

P/FCF

79.5225

P/OCF

34.9529

P/CF

34.9529

PEG

3.2083

P/S

5.7573

EV Multiple

31.1289

P/FV

-6.2888

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 02, 06:05 MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million GlobeNewswire Inc. Nov 06, 06:15 MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 Diabetes GlobeNewswire Inc. Oct 30, 06:15 MannKind Expands Patent Portfolio With New Clofazimine Formulation Patent

Revenue Product Segmentation